{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"276"}],"units":"Participants"}],"title":"Age, Adults (27-90 years)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"266"}],"units":"Participants"}],"title":"MM Type, Heavy chain, IgA"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"266"}],"units":"Participants"}],"title":"MM Type, Heavy chain, IgD"},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"266"}],"units":"Participants"}],"title":"MM Type, Heavy chain, IgG"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"266"}],"units":"Participants"}],"title":"MM Type, Heavy chain, IgM"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"266"}],"units":"Participants"}],"title":"MM Type, Heavy chain, No Heavy Chain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"276"}],"units":"Participants"}],"title":"MM Type, Light Chain, No Light Chain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"59.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"276"}],"units":"Participants"}],"title":"MM Type, Light Chain, Kappa"},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"276"}],"units":"Participants"}],"title":"MM Type, Light Chain, Lambda"},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"235"}],"units":"Participants"}],"title":"MM Type, Bence Jones Protein, Yes"},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"267"}],"units":"Participants"}],"title":"ISS Disease Stage I"},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"267"}],"units":"Participants"}],"title":"ISS Disease Stage II"},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"267"}],"units":"Participants"}],"title":"ISS Disease Stage III"},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"276"}],"units":"Participants"}],"title":"CRAB Signs, None"},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"241"}],"units":"Participants"}],"title":"CRAB Signs, Some, Increase in blood calcium levels"},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"241"}],"units":"Participants"}],"title":"CRAB Signs, Some, Renal failure"},{"categories":[{"measurements":[{"groupId":"OG000","value":"52.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"241"}],"units":"Participants"}],"title":"CRAB Signs, Some, Anemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"241"}],"units":"Participants"}],"title":"CRAB Signs, Some, Bone lesions"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Cytogenetic abnormalities, t (4;14)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Cytogenetic abnormalities, t (11;14)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Cytogenetic abnormalities, t (14;16)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Cytogenetic abnormalities, Trisomies"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Cytogenetic abnormalities, d (17p)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Cytogenetic abnormalities, g (1q)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Cytogenetic abnormalities, Other"},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Risk, High"},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Risk, Standard"},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Risk, Intermediate"},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"title":"Risk, Other"},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"195"}],"units":"Participants"}],"title":"ECOG Status, 0"},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"195"}],"units":"Participants"}],"title":"ECOG Status, 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"195"}],"units":"Participants"}],"title":"ECOG Status, 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"195"}],"units":"Participants"}],"title":"ECOG Status, 3"}],"denoms":[{"counts":[{"groupId":"OG000","value":"276"}],"units":"Participants"}],"description":"Clinical variables at Diagnosis included age,MM type(heavy/light chain/Bence-Jones protein), international staging system(ISS),disease stage(I:low risk,β2-Microglobulin\\<3.5mg/L and albumin≥3.5g/dL,II:not stage I or III,III:high risk,β2-Microglobulin≥5.5mg/L),calcium,renal insufficiency,anemia or bone lesions(CRAB) signs(serum calcium\\>0.25mmol/L upper limit of normal,renal failure-creatinine clearance\\<40mL/min/serum creatinine\\>117μmol/L, anemia:reduction of hemoglobin(Hb)\\>2g/dL below lower limit of normal or Hb\\<10g/dL,bone lesions 1/more osteolytic lesion,cytogenetic abnormalities(t\\[4;14\\],t\\[11;14\\],t\\[14;16\\],t\\[14;20\\],t\\[6;14\\],trisomies,d\\[17p\\],g\\[1q\\]/others), risk according to cytogenetic profile(standard:trisomies,t\\[11;14\\];t\\[6;14\\],intermediate:t\\[4;14\\],g\\[1q\\], high:d\\[17p\\],t\\[14;16\\],t\\[14;20\\],other), eastern cooperative oncology group(ECOG) status (0:fully active,1:restricted physical activity,2:ambulatory,unable to carry out any work,3:capable of limited selfcare,4:completely disabled,5:dead).","groups":[{"description":"Adult participants with a diagnosis of MM received at least one previous treatment line (standard care of treatment) and experienced symptomatic relapse and/or refractory disease in the previous 6 months, who were followed-up at the time of the study visit. No intervention was administered in this study.","id":"OG000","title":"Multiple Myeloma (MM) Participants"}],"paramType":"NUMBER","populationDescription":"All participants eligible for analyses were included. Number analyzed is the number of participants with data available for analyses for the specific category. Participants are repeated for multiple CRAB signs and cytogenic abnormalities. Percentages were rounded off.","reportingStatus":"POSTED","timeFrame":"Day 1","title":"Percentage of MM Participants Categorized by Clinical Variables at Diagnosis","type":"PRIMARY","unitOfMeasure":"percentage of participants"}